FDA Person
FDABarbara A. Marsden
View detailed information about Barbara A. Marsden, including compliance records, violations, and related data.
Person Profile
Comprehensive profile of Barbara A. Marsden, including their role, qualifications, and regulatory activities.
Recent Records (17)
WARNING_LETTER - Technological Medical Advancements LLC
WARNING_LETTER
WARNING_LETTER - ASP Global, LLC.
WARNING_LETTER
WARNING_LETTER - Unetixs Vascular, Inc.
WARNING_LETTER
WARNING_LETTER - Envoy
WARNING_LETTER
WARNING_LETTER - Flextronics America LLC
WARNING_LETTER
WARNING_LETTER - Abbott Diabetes Care, Inc.
WARNING_LETTER
WARNING_LETTER - Meridian Bioscience Inc
WARNING_LETTER
WARNING_LETTER - MAST Biosurgery USA Inc
WARNING_LETTER
WARNING_LETTER - Diasol, Inc
WARNING_LETTER
WARNING_LETTER - Beta Bionics, Inc
WARNING_LETTER
WARNING_LETTER - Exactech, Inc.
WARNING_LETTER
WARNING_LETTER - Longhorn Vaccines And Diagnostics LLC
WARNING_LETTER
WARNING_LETTER - IsoTis OrthoBiologics, Inc.
WARNING_LETTER
WARNING_LETTER - Physitemp Instruments, LLC
WARNING_LETTER
WARNING_LETTER - Medline Industries, LP
WARNING_LETTER
WARNING_LETTER - 3B Medical, Inc. dba Reach Health, Inc.
WARNING_LETTER
WARNING_LETTER - BMC Medical Co., Ltd.
WARNING_LETTER
Person Information
Name
Barbara A. Marsden
Title
Acting Director
Role
ISSUING OFFICER
ID: 985d635d-6ed5-4512-bc3e-c3aedca2be7d
Get More Insights
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
1.5M+ regulatory data points
Real-time compliance monitoring
Interactive analytics dashboard
Looking for more people? Our platform provides access to thousands of FDA people with advanced search and filtering capabilities.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.